Almitrine Bismesylate + Raubasine
Indications
Almitrine Bismesylate + Raubasine is used for:
Cerebrovascular insufficiency, Functional rehabilitation after cerebrovascular accidents, Auditory, Vestibular and visual disorders of ischaemic aetiology, Stroke
Adult Dose
Adult: PO
Auditory, vestibular and visual disorders of ischaemic aetiology; Cerebrovascular insufficiency; Functional rehabilitation after cerebrovascular accidents
Per tab contains almitrine 30 mg and raubasine 10 mg:
1 tab twice daily.
Child Dose
Renal Dose
Administration
Contra Indications
Concurrent usage with MAOIs.
Precautions
Pregnancy. Long term treatment may result in numbness, prickling or formication effects in the lower limbs which may, in rare cases, lead to treatment withdrawal.
Pregnancy-Lactation
Interactions
Not to be used concurrently with other almitrine-containing preparations.
Potentially Fatal: MAOIs.
Adverse Effects
Side effects of Almitrine Bismesylate + Raubasine :
Mild GI disorders, sleep disturbances, palpitations, anxiety, dizziness.
Rarely, wt loss, peripheral neuropathy with abnormal sensations in the lower limbs.
Mechanism of Action
Almitrine and raubasine work together to increase the amount of oxygen brought to the brain and neurosensory tissue, by increasing the oxygen content of arterial blood.